Outcomes in pulmonary sarcoidosis: results of a newly implemented prednisone protocol.

Kampstra, Nynke; Van der Wees, Philip J; Van Beek, Frouke T; Biesma, Douwe H; Grutters, Jan C; Van der Nat, Paul B.

Afiliação

Kampstra N; St. Antonius Hospital. nynkekampstra@gmail.com.
Van der Wees PJ; 3 Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Nijmegen, The Netherlands 4 Radboudumc, Department of Rehabilitation, Nijmegen, The Netherlands. philip.vanderwees@radboudumc.nl.
Van Beek FT; 2 Sint Antonius Hospital, Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, Nieuwegein, The Netherlands. f.van.beek@antoniusziekenhuis.nl.
Biesma DH; 5 Leiden Universitair Medisch Centrum, Data-driven Healthcare Improvement, Leiden, The Netherlands 6 UMC Utrecht, Department of Internal Medicine, Utrecht, The Netherlands. d.h.biesma@lumc.nl.
Grutters JC; 2 Sint Antonius Hospital, Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, Nieuwegein, The Netherlands 7 UMC Utrecht, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands. j.grutters@antoniusziekenhuis.nl.
Van der Nat PB; 1 Sint Antonius Hospital, Department of Value-Based Healthcare, Nieuwegein, The Netherlands. paul.van.der.nat@antoniusziekenhuis.nl.

Sarcoidosis Vasc Diffuse Lung Dis ; 40(1): e2023009, 2023 Mar 28.

Article em En | MEDLINE | ID: mdl-36975054

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article